CN113499393A - Composition with gastric mucosa injury protection effect and preparation method thereof - Google Patents

Composition with gastric mucosa injury protection effect and preparation method thereof Download PDF

Info

Publication number
CN113499393A
CN113499393A CN202110931376.4A CN202110931376A CN113499393A CN 113499393 A CN113499393 A CN 113499393A CN 202110931376 A CN202110931376 A CN 202110931376A CN 113499393 A CN113499393 A CN 113499393A
Authority
CN
China
Prior art keywords
parts
extract
weight
composition
portions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN202110931376.4A
Other languages
Chinese (zh)
Other versions
CN113499393B (en
Inventor
朱志铭
赵大鹏
张赞
李丽丽
马辉
韩烁培
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hebei Yuzhilin Pharmaceutical Co ltd
Original Assignee
Hebei Yuzhilin Pharmaceutical Co ltd
Hebei Yuzhilin Biotechnology Co ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hebei Yuzhilin Pharmaceutical Co ltd, Hebei Yuzhilin Biotechnology Co ltd filed Critical Hebei Yuzhilin Pharmaceutical Co ltd
Priority to CN202110931376.4A priority Critical patent/CN113499393B/en
Publication of CN113499393A publication Critical patent/CN113499393A/en
Application granted granted Critical
Publication of CN113499393B publication Critical patent/CN113499393B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06Fungi, e.g. yeasts
    • A61K36/07Basidiomycota, e.g. Cryptococcus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06Fungi, e.g. yeasts
    • A61K36/062Ascomycota
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/75Rutaceae (Rue family)
    • A61K36/752Citrus, e.g. lime, orange or lemon
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/898Orchidaceae (Orchid family)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841Filling excipients; Inactive ingredients
    • A61K9/4858Organic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

The invention provides a composition with a gastric mucosa injury protection effect, which comprises the following components in parts by weight: 50-70 parts of hericium erinaceus extract, 40-60 parts of morchella esculenta extract, 30-50 parts of bletilla striata extract, 20-40 parts of fingered citron extract, 260 parts of sea buckthorn oil and 340 parts of beeswax. The morchella esculenta has the effects of harmonizing stomach, promoting digestion, eliminating phlegm and regulating qi; the common bletilla pseudobulb has the effects of astringing and promoting granulation, dissipating stagnation and removing blood stasis, promoting digestion and removing food retention, promoting granulation and removing necrotic tissue, regulating qi and dissipating stagnation, and is used as a ministerial drug together to increase the bleeding amount of gastric mucosa, promote oxygen supply, enhance resistance, and smoothen the blood circulation of gastric mucosa to smooth qi and blood of organism. The fingered citron is an adjuvant drug, has the effects of promoting the circulation of qi, tonifying liver, warming stomach, strengthening spleen, stopping vomiting and the like, is soft in nature and weak, treats both liver and spleen without damaging vital qi, is flexible and suitable in the formula and plays a good auxiliary role.

Description

Composition with gastric mucosa injury protection effect and preparation method thereof
Technical Field
The invention belongs to the technical field of traditional Chinese medicines, and particularly relates to a composition with a gastric mucosa injury protection effect and a preparation method thereof.
Background
With the acceleration of the pace of life in modern society, the social, psychological and working pressure borne by people is increased, so that the incidence rate of gastric mucosa diseases is correspondingly increased. And the fast-paced life style, the intense work and study, and the frequent reasons of stomach mucosa injury caused by over-drinking wine and the like. The incidence of a disease is high in both developed and developing countries as a worldwide disease. It is reported that more than 10% of people in our national population suffer from gastric ulcer, about 25% suffer from various gastritis, and the total number of patients suffering from gastric diseases in the country is nearly 3 hundred million.
The gastric mucosa defense mechanism is a complex system with multiple angles, layers and properties, and is mainly divided into four stages. The first defense is the mucus-bicarbonate-phospholipid barrier, the second is the gastric mucosal barrier composed of mucosal epithelial cells, the third relies on mucosal microcirculation, and the mucosal immune system constitutes the fourth defense. In addition, there are other defenses such as gastric mucosal self-repair, gastric mucosal blood flow, etc. The analysis of the pathogenesis of gastric mucosa injury from the perspective of traditional Chinese medicine is as follows: the insufficiency of middle-jiao leads to the disorder of transportation and reception and the lack of the source of the transformation, so that the qi movement is not smooth, the obstruction of the vessels and collaterals and the obstruction of the blood and qi movement can be caused after long-term accumulation, the stomach is not nourished, and the further development can lead to the transformation of the intestines and the cancer.
At present, the drugs for treating the loss of the gastric mucosa on the market comprise antacids (sodium bicarbonate and the like), gastric mucosa protective agents (prostaglandin and derivatives thereof, aluminum agents, bismuth agents, teprenone, issorafenib, rebamipide and the like), anti-helicobacter pylori drugs and the like. However, the medicines have side effects, and the problems of tolerance, reduced curative effect and repeated attack and temporary solution but not permanent solution of the disease easily occur to human bodies after long-term administration, and the traditional Chinese medicines mainly care, re-care, temporary solution and permanent solution. Therefore, the search for a high-efficiency traditional Chinese medicine composition with the function of protecting gastric mucosal injury becomes an important and urgent task.
Disclosure of Invention
The invention aims to provide a traditional Chinese medicine composition with a protection effect on gastric mucosa injury and a preparation method and application thereof.
In order to achieve the above object, the present invention provides the following technical solutions:
a composition with a gastric mucosa injury protection effect comprises the following components in parts by weight:
components Parts by weight
Hericium erinaceum extract 50-70 parts of
Morchella extract 40-60 parts
Bletilla striata extract 30-50 parts of
Extract of finger citron 20-40 parts of
Sea buckthorn oil 260 portion to 340 portions
Beeswax (Cera flava) 10-30 parts of
Further, the composition with the gastric mucosa injury protection effect comprises the following components in parts by weight:
components Parts by weight
Hericium erinaceum extract 55 to 65 portions of
Morchella extract 45 to 55 portions of
Bletilla striata extract 35-45 parts of
Extract of finger citron 25-35 parts of
Sea buckthorn oil 280-320 parts
Beeswax (Cera flava) 15-25 parts of
Further, the composition with the gastric mucosa injury protection effect comprises the following components in parts by weight:
components Parts by weight
Hericium erinaceum extract 58 to 62 portions of
Morchella extract 47-53 parts
Bletilla striata extract 37-43 parts of
Extract of finger citron 28-32 parts
Sea buckthorn oil 290 part by weight of 310 parts
Beeswax (Cera flava) 17-23 parts
Preferably, in one embodiment of the present invention, a composition having a gastric mucosal lesion protecting effect comprises the following components in parts by weight:
components Parts by weight
Hericium erinaceum extract 60 portions of
Morchella extract 50 portions of
Bletilla striata extract 40 portions of
Extract of finger citron 30 portions of
Sea buckthorn oil 300 portion to 310 portion
Beeswax (Cera flava) 20-25 parts of
Preferably, in another embodiment of the present invention, a composition having a gastric mucosal lesion protecting effect comprises the following components in parts by weight:
components Parts by weight
Hericium erinaceum extract 60 portions of
Morchella extract 50 portions of
Bletilla striata extract 40 portions of
Extract of finger citron 30 portions of
Sea buckthorn oil 305 parts of
Beeswax (Cera flava) 22 portions of
The Hericium erinaceus extract, morel extract, rhizoma bletillae extract and fructus Citri Sarcodactylis extract in the composition can be provided by Jiangxi Jiahe Biotech GmbH, and can also be prepared by other extraction methods.
The composition can be prepared into tablets, granules, hard capsules, soft capsules, tablets, powder, pills and oral liquid, and preferably soft capsules.
Another aspect of the present invention is to provide a method for preparing the above composition having a gastric mucosal lesion protecting effect.
A method for preparing a composition with a gastric mucosa injury protection effect comprises the following steps:
1) respectively taking 50-70 parts of hericium erinaceus extract, 40-60 parts of morchella esculenta extract, 30-50 parts of rhizoma bletillae extract and 20-40 parts of fingered citron extract according to weight, and uniformly mixing for later use.
2) Heating to prepare capsule wall materials, wherein the raw materials comprise gelatin, glycerol and water.
3) Uniformly mixing the traditional Chinese medicine powder obtained in the step 1), 340 parts of seabuckthorn oil 260-30 parts of beeswax.
4) Pressing the soft capsules: the weight of the core material in each soft capsule is 0.1-0.5g, and the traditional Chinese medicine soft capsule is prepared.
Further, in the step 4), the weight of the core material in each soft capsule is preferably 0.2 g.
In the traditional Chinese medicine composition with the auxiliary protection function on the gastric mucosa injury, the pharmacological actions of the components are as follows:
hericium erinaceus is a fruit body of Hericium erinaceus (Bull. ex Fr.) Pers, a family of the Bacteromycetes, and is a rare edible and medicinal fungus. Has neutral nature and sweet taste, and has effects of invigorating spleen and stomach, softening hard masses, and eliminating abdominal mass, contains various components such as organic acid and its ester, saponins, saccharide, etc., and can be used for treating gastric ulcer, duodenal ulcer, neurasthenia, hepatitis B, chronic gastritis, and digestive tract tumor. Modern pharmacological research shows that the hericium erinaceus polysaccharide can increase the blood flow of gastric mucosa, so that stress gastric mucosa injury is treated. And the catalyst has a catalytic enhancement effect on various factors in gastric mucosa tissues, so that the defense capability is enhanced, and the aims of protecting the gastric mucosa and resisting ulcer are fulfilled. The hericium erinaceus can reduce the area and the volume of gastric ulcer of a chronic gastric mucosa injury model caused by glacial acetic acid, and the hericium erinaceus extract has an auxiliary protection effect on gastric mucosa injury. The Hericium erinaceus fruiting body polysaccharide can reduce gastric mucosa injury index caused by ethanol, gastric ulcer index caused by indomethacin, and gastric ulcer index caused by acetic acid, and simultaneously increase gastric juice pH value and reduce pepsin activity. The results show that the hericium erinaceus sporocarp polysaccharide and the hericium erinaceus mycelium polysaccharide have obvious inhibition effects on acute ulcer of a rat caused by pylorus ligation and chronic ulcer of the rat caused by acetic acid, have protection effects on gastric mucosa injury caused by ethanol and indomethacin, and simultaneously can reduce the activities of gastric acid and pepsin and have protection effects on chronic gastric mucosa injury.
Morchella is a rare edible fungus, which is named because the surface of the cap is uneven and is like morchella. The book of Xinhua materia medica compendium records that the morchella esculenta has the functions of harmonizing stomach, promoting digestion, eliminating phlegm and regulating qi. Modern medical research shows that the morchella aqueous extract has obvious effects on pylorus ligation gastric ulcer models, acetic acid burning gastric ulcer models, ethanol induced gastric ulcer models and water immersion stress gastric ulcer models, and the reduction of ulcer indexes (areas) and the reduction of gastric juice amount show that the morchella aqueous extract has good treatment and prevention effects on gastric ulcer caused by gastric acid, chemistry and stress conditions. In addition, the research proves that the morchella aqueous extract can not only strengthen the gastrointestinal peristalsis of normal mice and has the effect similar to gastrointestinal motivators, but also inhibit the hyperfunction of the mice on the gastrointestinal function caused by neostigmine load.
Bletilla striata is a dried tuber of the plant Bletilla striata (Thunb.) reichb.f. of the family orchidaceae. Enters lung, liver and stomach meridians, and has effects of promoting blood circulation, stopping bleeding, promoting granulation, and protecting skin. The chemical components of the rhizoma bletillae mainly comprise glycosides, bibenzyls, phenanthrenes, quinones, biphenyls, dihydrophenanthrenes, anthocyanidins, steroids, triterpenes, phenolic acids and the like. Modern pharmacological experiment research proves that the bletilla striata can relieve the aspirin-induced gastric ulcer model of rats, acetic acid gastric ulcer, pylorus ligation ulcer and experimental gastric ulcer of the gastric mucosa of the rats. The bletilla polysaccharide has obvious therapeutic action on acetic acid gastric ulcer of rats, and the therapeutic mechanism of the bletilla polysaccharide can enhance the oxidation resistance of gastric mucosa, inhibit the generation of free radicals, promote the epithelial cell proliferation of gastric mucosa at local ulcer and strengthen the repair of damaged tissues. Clinical tests show that the bletilla striata can remarkably adjust the erythrocyte sedimentation rate and the C-reactive protein level of patients and has an immunoregulation effect on patients with ulcerative colitis; the bletilla striata and angelica sinensis powder has the effects of stopping bleeding, nourishing blood, resisting bacteria, diminishing inflammation and easing pain, and has a remarkable effect of treating upper gastrointestinal hemorrhage. The results show that the bletilla has the functions of astringing, stopping bleeding, promoting granulation, dissipating stagnation and removing necrosis, the mucous membrane barrier of the gastric ulcer patient is damaged due to the ulcer, and the bletilla has high viscosity, so that a membrane with a certain thickness is easily formed in the stomach and is attached to the ulcer surface, further invasion of gastric acid, pepsin and other physical and chemical factors to the ulcer is prevented, healing and repairing of the ulcer are facilitated, and the healing, stopping bleeding and promoting granulation effects of the bletilla are exerted.
The root, stem, leaf, flower and fruit of Citrus plant of Rutaceae can be used as medicine, and is pungent, bitter, sweet, warm and nontoxic; it has the functions of regulating qi, eliminating phlegm, stopping vomiting, relieving flatulence, soothing liver, strengthening spleen, regulating stomach and other medicinal functions. The specific substances of the volatile oil and the flavonoid substances in the fingered citron can promote the increase of gastric mucus and keep the balance of gastric acid, thereby inhibiting the formation of gastric ulcer.
The oleum Hippophae contains unsaturated fatty acid, vitamins, and trace elements, and has high nutritive value. Modern researches show that the seabuckthorn seed oil has a protective effect on liver injury caused by carbon tetrachloride, and can protect gastric mucosa by stimulating the proximal small intestine to release multiple gastrointestinal hormones.
The traditional Chinese medicine composition can be added with one or more of dextrin, maltodextrin, beta-cyclodextrin, soluble starch, erythritol, mogroside, isomalt and the like as auxiliary materials, and prepared into products in the forms of tablets, granules, hard capsules, soft capsules, tablets, powder, pills, oral liquid and the like according to the production method of modern traditional Chinese medicine products or foods.
Compared with the prior art, the hericium erinaceus extract, the morchella esculenta extract, the bletilla striata extract and the fingered citron extract are creatively prepared into the traditional Chinese medicine composition according to the traditional Chinese medicine theory aiming at the deficiency of qi in spleen and stomach and the unsmooth qi and blood of pathogenesis, and the hericium erinaceus extract in the formula can tonify the spleen and stomach, particularly is good at spleen and stomach channels and is a monarch drug. The morchella esculenta has the effects of harmonizing stomach, promoting digestion, eliminating phlegm and regulating qi; the common bletilla pseudobulb has the effects of astringing and promoting granulation, dissipating stagnation and removing blood stasis, promoting digestion and removing food retention, promoting granulation and removing necrotic tissue, regulating qi and dissipating stagnation, and is used as a ministerial drug together to increase the bleeding amount of gastric mucosa, promote oxygen supply, enhance resistance, and smoothen the blood circulation of gastric mucosa to smooth qi and blood of organism. The fingered citron is an adjuvant drug, has the effects of promoting the circulation of qi, tonifying liver, warming stomach, strengthening spleen, stopping vomiting and the like, is soft in nature and weak, treats both liver and spleen without damaging the body resistance, is flexible and suitable in the formula and plays a good auxiliary role.
The traditional Chinese medicine composition has obviously better treatment effect on gastric mucosa injury than that of a single hericium erinaceus extract or other component composition, and has unexpected technical effect.
The invention provides the pharmaceutical composition with the function of protecting gastric mucosa from injury, which has obvious effect and no toxic or side effect: (1) the test result of a maximum tolerance method shows that the MTD of the pharmaceutical composition provided by the invention to mice of two sexes is more than 20.0 g/kg.bw; the sample was of the nontoxic grade according to the acute toxicity grading criteria. (2) And (3) genetic toxicity test: the Ames test result is negative; the result of the mouse marrow pleochromocyte micronucleus test is negative; the result of the mouse sperm aberration test is negative; the results of the experiment of feeding the sample 30d to the rat show that the sample 30d has no toxic effect on various observation indexes of the rat.
Detailed Description
The invention discloses a composition with a gastric mucosa injury protection effect and a preparation method thereof, and the composition can be realized by combining the relevant principles of traditional Chinese medicines and properly improving process parameters by taking the contents of the composition as reference by the technical personnel in the field. It is expressly intended that all such similar substitutes and modifications apparent to those skilled in the art are deemed to be within the scope of the invention. While the invention has been described in terms of preferred embodiments, it will be apparent to those skilled in the art that variations may be applied, or changes and combinations may be made, in the methods and applications described herein to achieve and use the inventive techniques without departing from the spirit, scope, and content of the invention.
For a better understanding of the invention, and not as a limitation on the scope thereof, all numbers expressing quantities, percentages, and other numerical values used in this application are to be understood as being modified in all instances by the term "about". At the very least, each numerical parameter should at least be construed in light of the number of reported significant digits and by applying ordinary rounding techniques.
The present invention is further illustrated by the following examples, which are not intended to limit the invention in any way.
The hericium erinaceus extract, the morchella esculenta extract, the bletilla striata extract and the fingered citron extract used in the application are all provided by Jiangxi Jiahe biological science and technology company Limited. Can also be prepared by the method of the preparation example of the invention.
Preparation example 1: hericium erinaceum extract
1) Taking dried hericium erinaceus, crushing, and sieving with a 120-mesh sieve to obtain dried hericium erinaceus powder;
2) adding Hericium erinaceus dry powder into deionized water, boiling for 30-45min, stirring, centrifuging, and separating supernatant a;
3) adding deionized water into the precipitate, boiling for 30-45min, stirring, centrifuging, and separating to obtain supernatant b;
4) mixing the supernatant a and the supernatant b, concentrating, and freeze-drying to obtain Hericium erinaceum extract.
Preparation example 2: morchella extract
1) Taking morchella esculenta, cleaning and drying the morchella esculenta, crushing the morchella esculenta, sieving the morchella esculenta with a 100-mesh sieve to obtain powder, adding 0.1-1% of 5' -phosphodiesterase solution by weight of the powder into the powder, carrying out enzymolysis for 2 hours at 50 ℃ under the condition that the pH value is 5-6, then carrying out enzyme deactivation treatment, and filtering to obtain a first morchella esculenta enzymolysis solution and a first filter residue;
2) adding papain solution 1-5% of the first filter residue, performing enzymolysis at 45 deg.C and pH 4.5-5.5 for 1.5 hr, inactivating enzyme, and filtering to obtain second enzymolysis solution of Morchella esculenta and second filter residue;
3) adding 0.1-0.5% of 5' -phosphodiesterase solution into the second filter residue, performing enzymolysis at 50-55 deg.C and pH 6-7 for 2 hr, inactivating enzyme, filtering to obtain a third enzymolysis solution of Morchella esculenta,
4) mixing the three enzymolysis solutions, and freeze drying to obtain Morchella esculenta extract.
Preparation example 3: and (3) common bletilla pseudobulb extract:
pulverizing rhizoma Bletillae crude product, sieving with 80-100 mesh sieve, weighing sieved rhizoma Bletillae powder, adding 8-10 times of 95% ethanol, reflux extracting for 3-5 times, each time for 0.5-1 hr, mixing extractive solutions, and freeze drying to obtain dry powder rhizoma Bletillae extract.
Preparation example 4: fingered citron extract:
1) soaking: taking dried fingered citron fruits, crushing the dried fingered citron fruits into powder by a traditional Chinese medicine crusher, taking 80% ethanol as an extraction solvent, and mixing the materials according to a material-liquid ratio of 1: 20, soaking for one week.
2) And (3) freeze drying: and (4) carrying out suction filtration on the soaked sample, taking out filtrate, and carrying out freeze drying to obtain the fingered citron extract.
Example 1: composition comprising a metal oxide and a metal oxide
The method comprises the following steps:
components Number of parts Remarks for note
Hericium erinaceum extract 60 portions of Preparation example 1
Morchella extract 50 portions of Preparation example 2
Bletilla striata extract 40 portions of Preparation example 3
Extract of finger citron 30 portions of Preparation example 4
Sea buckthorn oil 305 parts of -
Beeswax (Cera flava) 22 portions of -
Secondly, the preparation method comprises the following steps:
1) taking 60 parts of hericium erinaceus extract, 50 parts of morchella esculenta extract, 40 parts of rhizoma bletillae extract and 30 parts of fingered citron extract according to weight parts, and uniformly mixing for later use.
2) Heating to prepare the soft capsule wall material, wherein the raw materials comprise gelatin, glycerol and water.
3) Uniformly mixing the traditional Chinese medicine powder obtained in the step 1), 305 parts of seabuckthorn oil and 22 parts of beeswax.
4) Pressing the soft capsules: the weight of the core material in each soft capsule is 0.2g, and the traditional Chinese medicine soft capsule is prepared.
Example 2: composition comprising a metal oxide and a metal oxide
The method comprises the following steps:
components Number of parts Remarks for note
Hericium erinaceum extract 50 portions of Jianxi Jiahe biology
Morchella extract 40 portions of Jianxi Jiahe biology
Bletilla striata extract 30 portions of Jianxi Jiahe biology
Extract of finger citron 20 portions of Jianxi Jiahe biology
Sea buckthorn oil 260 portions of -
Beeswax (Cera flava) 10 portions of -
Secondly, the preparation method comprises the following steps:
1) respectively taking 50 parts of hericium erinaceus extract, 40 parts of morchella esculenta extract, 30 parts of rhizoma bletillae extract and 20 parts of fingered citron extract according to weight, and uniformly mixing for later use.
2) Heating to prepare a capsule wall material, wherein the raw materials comprise gelatin, glycerol and water; .
3) Uniformly mixing the traditional Chinese medicine powder obtained in the step 1), 260 parts of seabuckthorn oil and 10 parts of beeswax.
4) Pressing the soft capsules: the weight of the core material in each soft capsule is 0.2g, and the traditional Chinese medicine soft capsule is prepared.
Example 3: composition comprising a metal oxide and a metal oxide
The method comprises the following steps:
components Number of parts Remarks for note
Hericium erinaceum extract 60 portions of Preparation example 1
Morchella extract 48 portions of Preparation example 2
Bletilla striata extract 42 portions of Preparation example 3
Extract of finger citron 30 portions of Preparation example 4
Sea buckthorn oil 298 parts by weight -
Beeswax (Cera flava) 22 portions of -
Secondly, the preparation method comprises the following steps:
1) taking 60 parts of hericium erinaceus extract, 48 parts of morchella esculenta extract, 42 parts of rhizoma bletillae extract and 30 parts of fingered citron extract according to weight, and uniformly mixing for later use.
2) Heating to prepare capsule wall materials, wherein the raw materials comprise gelatin, glycerol and water.
3) Mixing the traditional Chinese medicine powder obtained in the step 1) with 298 parts of seabuckthorn oil and 22 parts of beeswax uniformly.
4) Pressing the soft capsules: the weight of the core material in each soft capsule is 0.3g, and the traditional Chinese medicine soft capsule is prepared.
Example 4: composition comprising a metal oxide and a metal oxide
The method comprises the following steps:
components Number of parts Remarks for note
Hericium erinaceum extract 60 portions of Preparation example 1
Morchella extract 53 portions of Preparation example 2
Bletilla striata extract 37 portions of Preparation example 3
Extract of finger citron 28 portions of Preparation example 4
Sea buckthorn oil 302 portions of -
Beeswax (Cera flava) 20 portions of -
Secondly, the preparation method comprises the following steps:
1) taking 60 parts of hericium erinaceus extract, 53 parts of morchella esculenta extract, 37 parts of rhizoma bletillae extract and 28 parts of fingered citron extract according to weight, and uniformly mixing for later use.
2) Heating to prepare capsule wall materials, wherein the raw materials comprise gelatin, glycerol and water.
3) Uniformly mixing the traditional Chinese medicine powder obtained in the step 1), 302 parts of seabuckthorn oil and 20 parts of beeswax.
4) Pressing the soft capsules: the weight of the core material in each soft capsule is 0.4g, and the traditional Chinese medicine soft capsule is prepared.
Example 5: composition comprising a metal oxide and a metal oxide
The method comprises the following steps:
components Number of parts Remarks for note
Hericium erinaceum extract 58 portions of Jianxi Jiahe biology
Morchella extract 53 portions of Jianxi Jiahe biology
Bletilla striata extract 43 portions of Jianxi Jiahe biology
Extract of finger citron 28 portions of Jianxi Jiahe biology
Sea buckthorn oil 290 portions of -
Beeswax (Cera flava) 23 portions of -
Secondly, the preparation method comprises the following steps:
1) and uniformly mixing 58 parts of hericium erinaceus extract, 53 parts of morchella esculenta extract, 43 parts of rhizoma bletillae extract and 28 parts of fingered citron extract according to weight for later use.
2) Heating to prepare capsule wall materials, wherein the raw materials comprise gelatin, glycerol and water.
3) Uniformly mixing the traditional Chinese medicine powder obtained in the step 1), 290 parts of seabuckthorn oil and 23 parts of beeswax.
4) Pressing the soft capsules: the weight of the core material in each soft capsule is 0.5g, and the traditional Chinese medicine soft capsule is prepared.
Example 6: composition comprising a metal oxide and a metal oxide
The method comprises the following steps:
components Number of parts Remarks for note
Hericium erinaceum extract 62 portions of Preparation example 1
Morchella extract 47 parts of Preparation example 2
Bletilla striata extract 37 portions of Preparation example 3
Extract of finger citron 32 portions of Preparation example 4
Sea buckthorn oil 310 portions of -
Beeswax (Cera flava) 17 portions of -
Secondly, the preparation method comprises the following steps:
1) and uniformly mixing 62 parts of hericium erinaceus extract, 47 parts of morchella esculenta extract, 37 parts of rhizoma bletillae extract and 32 parts of fingered citron extract according to weight for later use.
2) Heating to prepare capsule wall materials, wherein the raw materials comprise gelatin, glycerol and water.
3) Uniformly mixing the traditional Chinese medicine powder obtained in the step 1), 310 parts of seabuckthorn oil and 17 parts of beeswax.
4) Pressing the soft capsules: the weight of the core material in each soft capsule is 0.2g, and the traditional Chinese medicine soft capsule is prepared.
Comparative example 1: composition comprising a metal oxide and a metal oxide
The method comprises the following steps:
components Number of parts Remarks for note
Hericium erinaceum extract 60 portions of Preparation example 1
Sea buckthorn oil 305 parts of -
Beeswax (Cera flava) 22 portions of -
Secondly, the preparation method comprises the following steps: the same as in example 1.
Comparative example 2: composition comprising a metal oxide and a metal oxide
The method comprises the following steps:
components Number of parts Remarks for note
Hericium erinaceum extract 60 portions of Preparation example 1
Morchella extract 50 portions of Preparation example 2
Sea buckthorn oil 305 parts of -
Beeswax (Cera flava) 22 portions of -
Secondly, the preparation method comprises the following steps: the same as in example 1.
Comparative example 3: composition comprising a metal oxide and a metal oxide
The method comprises the following steps:
components Number of parts Remarks for note
Hericium erinaceum extract 60 portions of Preparation example 1
Bletilla striata extract 40 portions of Preparation example 3
Extract of finger citron 30 portions of Preparation example 4
Sea buckthorn oil 305 parts of -
Beeswax (Cera flava) 22 portions of -
Secondly, the preparation method comprises the following steps: the same as in example 1.
Example 7: evaluation of protective action of composition of the present invention on alcohol-induced gastric mucosal injury
1. Materials and methods
1.1 test substance: the compositions of examples 1-6, the hericium erinaceus extract of comparative example 1, and the compositions of comparative examples 2-3.
1.2 Experimental animals: SPF grade SD rats, male, weighing 180-.
1.3 Experimental methods: alcohol model adopting acute gastric mucosa injury
Dose grouping and test sample administration time: experiments were carried out by feeding 10 animals each of 11 groups of examples 1 to 6, comparative examples 1 to 3, blank control group and model control group with gavage volume of l.0ml/100g for 30 consecutive days, and feeding equal volume of physiological saline to the blank control group and the model control group.
1.3.2 Experimental procedures: after 30 days of gastric lavage of each group, all animals were strictly fasted for 24h (without water deprivation) and were not given test substances, except for the blank control group, all animals of the test groups were given 1.0 ml/animal of absolute ethanol, the animals were sacrificed after 1h, the intact stomach was exposed, the pylorus was ligated, an appropriate amount of 10% formaldehyde solution was perfused, fixed for 20min, then cut open along the greater curvature of the stomach, the stomach contents were washed, the gastric mucosa was developed, and the length and width of the bleeding spot or the bleeding band were measured with a vernier caliper. The scoring criteria were: the score for gastric injury is the number of bleeding points + length of the bleeding zone + width of the bleeding zone x 2 (double score because the severity of the injury represented by the width is much greater than the length).
1.4 data processing: statistics are carried out by a pairwise comparison method of mean numbers between a plurality of experimental groups and a plurality of control groups.
2. As a result: the results are shown in Table 1.
Table 1: results of alcohol-induced gastric mucosal injury with the inventive compositions
Experimental group Number of animals Gastric injury scoring
Blank control group 10 0.00±0.00
Model control group 10 27.73±5.59
Example 1 10 15.73±5.66**##
Example 2 10 15.12±5.00**##
Example 3 10 16.94±5.69**#
Example 4 10 17.43±5.27**#
Example 5 10 18.45±6.34**#
Example 6 10 18.47±5.02**#
Comparative example 1 group 10 22.92±6.99*
Comparative example 2 group 10 22.36±5.49*
Comparative example 3 group 10 22.12±5.11*
Note: p < 0.05; p <0.01 compared to model control,
#P<0.05,##P<0.01, compared to comparative example 1.
And (4) conclusion: the effect of the pharmaceutical composition on protecting gastric mucosa injury is evaluated by an acute gastric mucosa injury model, and the result shows that compared with a model control group, the pharmaceutical composition provided by the invention can obviously reduce the gastric mucosa injury and has very obvious difference (P < 0.01); compared with the singly-used hericium erinaceus extract in the comparative example 1, the pharmaceutical composition provided by the invention can obviously reduce the damage of gastric mucosa, and has obvious difference (P <0.05) or very obvious difference (P < 0.01). The pharmaceutical composition provided by the invention has a protection effect on gastric mucosa injury, and the hericium erinaceus extract, the morchella esculenta extract, the bletilla striata extract, the fingered citron extract and the like have a synergistic effect, so that the gastric mucosa injury is remarkably reduced.
Example 8: human body test eating test
1. Test subjects: selecting a patient with superficial gastritis as a subject, and the diagnosis criteria are: prolonged course of disease, with different degrees of clinical symptoms such as dyspepsia, epigastric pain, heartburn, belching, acid regurgitation, abdominal distension, etc., and mild tenderness of the upper abdomen. The test subjects were randomly divided into the group of example 1 and the control group according to their symptoms, and the disease course, age, sex and other factors were considered in the grouping, and each group was designed by self-control and two groups of control. The number of the complete data at the end of the test is 103, wherein 51 of the drug composition groups of the invention and 52 of the control groups.
2. The test method comprises the following steps: the subjects were to maintain their daily life and eating habits during the test period, the pharmaceutical composition group of the present invention took the samples prepared in example 12 times a day, 3 times a day (0.5 g/capsule), and the control group took Weijiean capsule (bio-engineering limited, Junshan mountain Jinan, 2 times a day, 4 capsules a time), continuously for 1 month.
3. Evaluation index
3.1 symptom score: stomachache, belching, acid regurgitation, abdominal distension, inappetence, anorexia and other clinical symptoms. The score was counted according to the severity of the symptoms (3 points of severe, 2 points of moderate, 1 point of mild).
Grading table for severity of symptoms
Figure BDA0003210890580000131
4. Results
(1) The symptom score, the disease course, the age, the sex and the blood pressure of the medicine composition group have no significant difference with those of a control group, and the balance among the groups is comparable.
(2) The inquiry and investigation are carried out on the mental, sleep, diet and defecation conditions of the test eaters, and the general conditions before and after two groups of test foods have no significant difference.
(3) The symptom integral conditions of the pharmaceutical composition group and the control group before and after the test are shown in table 2, the integral conditions of the two groups before the test are not significantly different, the integral conditions of the pharmaceutical composition group and the control group after the test are significantly different (P is less than 0.05), the integral conditions of the pharmaceutical composition group and the control group before the test are significantly different (P is less than 0.05), and the integral reduction is significantly better than that of the control group.
Table 2: change of symptom score before and after test eating
Figure BDA0003210890580000141
Injecting; p<0.05, compared with before tasting;#P<0.05, compared to the control group.

Claims (8)

1. A composition with a gastric mucosa injury protection effect comprises the following components in parts by weight:
components Parts by weight Hericium erinaceum extract 50-70 parts of Morchella extract 40-60 parts Bletilla striata extract 30-50 parts of Extract of finger citron 20-40 parts of Sea buckthorn oil 260 portion to 340 portions Beeswax (Cera flava) 10-30 parts of
2. The composition according to claim 1, characterized by consisting of, in parts by weight:
components Parts by weight Hericium erinaceum extract 58 to 62 portions of Morchella extract 47-53 parts Bletilla striata extract 37-43 parts of Extract of finger citron 28-32 parts Sea buckthorn oil 290 part by weight of 310 parts Beeswax (Cera flava) 17-23 parts
3. The composition according to claim 1, characterized by consisting of, in parts by weight:
components Parts by weight Hericium erinaceum extract 60 portions of Morchella extract 50 portions of Bletilla striata extract 40 portions of Extract of finger citron 30 portions of Sea buckthorn oil 300 portion to 310 portion Beeswax (Cera flava) 20-25 parts of
4. The composition according to claim 1, characterized by consisting of, in parts by weight:
Figure FDA0003210890570000011
Figure FDA0003210890570000021
5. the composition as claimed in claim 1, wherein the composition is in the form of tablet, granule, hard capsule, soft capsule, tablet, powder, pill, or oral liquid.
6. The composition as claimed in claim 1, wherein the composition is in the form of a soft capsule.
7. A method for preparing the composition with the effect of protecting gastric mucosa from injury according to claim 5 or 6, comprising the following steps:
1) respectively taking 50-70 parts of hericium erinaceus extract, 40-60 parts of morchella esculenta extract, 30-50 parts of bletilla extract and 20-40 parts of fingered citron extract according to weight, and uniformly mixing for later use;
2) heating to prepare a capsule wall material, wherein the raw materials comprise gelatin, glycerol and water;
3) uniformly mixing the traditional Chinese medicine powder obtained in the step 1), 340 parts of seabuckthorn oil 260-22 parts and 10-30 parts of beeswax;
4) pressing the soft capsules: the weight of the core material in each soft capsule is 0.1-0.5g, and the traditional Chinese medicine soft capsule is prepared.
8. The process according to claim 7, wherein in the step 4), the weight of the core material in each soft capsule is preferably 0.2 g.
CN202110931376.4A 2021-08-13 2021-08-13 Composition with gastric mucosa injury protection effect and preparation method thereof Active CN113499393B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202110931376.4A CN113499393B (en) 2021-08-13 2021-08-13 Composition with gastric mucosa injury protection effect and preparation method thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202110931376.4A CN113499393B (en) 2021-08-13 2021-08-13 Composition with gastric mucosa injury protection effect and preparation method thereof

Publications (2)

Publication Number Publication Date
CN113499393A true CN113499393A (en) 2021-10-15
CN113499393B CN113499393B (en) 2022-07-19

Family

ID=78016132

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202110931376.4A Active CN113499393B (en) 2021-08-13 2021-08-13 Composition with gastric mucosa injury protection effect and preparation method thereof

Country Status (1)

Country Link
CN (1) CN113499393B (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114558071A (en) * 2022-03-29 2022-05-31 赣南医学院 Traditional Chinese medicine composition for protecting stomach, preparation method and preparation containing traditional Chinese medicine composition
CN115154583A (en) * 2022-07-07 2022-10-11 北京美宝高科技有限责任公司 Capsule for promoting gastrointestinal mucosa self-repair and protecting gastrointestinal function and preparation method thereof
CN116262125A (en) * 2023-01-19 2023-06-16 哈尔滨美华生物技术股份有限公司 Lactobacillus casei L7-13 for protecting gastric mucosa and relieving gastritis and application thereof

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100998406A (en) * 2006-12-18 2007-07-18 东北虎药业股份有限公司 Health-care food with functions of improving immunocompetence and protecting damaged gastric mucosa and its preparing method
CN103536818A (en) * 2013-09-30 2014-01-29 山西五台山沙棘制品有限公司 Fingered citron and seabuckthorm seed soft capsules and preparation method thereof
CN105641433A (en) * 2016-01-01 2016-06-08 辽宁泰阳医药科技开发有限公司 Health food composition and preparation method thereof
CN106074718A (en) * 2016-08-10 2016-11-09 翔天农业开发集团股份有限公司 A kind of electuary treating gastropathy and preparation method thereof
CN112704223A (en) * 2019-12-30 2021-04-27 汤臣倍健股份有限公司 Composition with auxiliary gastric mucosa protection effect, application thereof and health food

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100998406A (en) * 2006-12-18 2007-07-18 东北虎药业股份有限公司 Health-care food with functions of improving immunocompetence and protecting damaged gastric mucosa and its preparing method
CN103536818A (en) * 2013-09-30 2014-01-29 山西五台山沙棘制品有限公司 Fingered citron and seabuckthorm seed soft capsules and preparation method thereof
CN105641433A (en) * 2016-01-01 2016-06-08 辽宁泰阳医药科技开发有限公司 Health food composition and preparation method thereof
CN106074718A (en) * 2016-08-10 2016-11-09 翔天农业开发集团股份有限公司 A kind of electuary treating gastropathy and preparation method thereof
CN112704223A (en) * 2019-12-30 2021-04-27 汤臣倍健股份有限公司 Composition with auxiliary gastric mucosa protection effect, application thereof and health food

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
戴玉成等: "《中国药用真菌图志》", 30 June 2013, 东北林业大学出版社 *
王希琳等: "《常用中药及配伍手册》", 31 July 2002, 内蒙古科学技术出版社 *

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114558071A (en) * 2022-03-29 2022-05-31 赣南医学院 Traditional Chinese medicine composition for protecting stomach, preparation method and preparation containing traditional Chinese medicine composition
CN114558071B (en) * 2022-03-29 2023-11-24 赣南医学院 Traditional Chinese medicine composition for protecting stomach, preparation method and preparation containing traditional Chinese medicine composition
CN115154583A (en) * 2022-07-07 2022-10-11 北京美宝高科技有限责任公司 Capsule for promoting gastrointestinal mucosa self-repair and protecting gastrointestinal function and preparation method thereof
CN116262125A (en) * 2023-01-19 2023-06-16 哈尔滨美华生物技术股份有限公司 Lactobacillus casei L7-13 for protecting gastric mucosa and relieving gastritis and application thereof
CN116262125B (en) * 2023-01-19 2023-11-14 哈尔滨美华生物技术股份有限公司 Lactobacillus casei L7-13 for protecting gastric mucosa and relieving gastritis and application thereof

Also Published As

Publication number Publication date
CN113499393B (en) 2022-07-19

Similar Documents

Publication Publication Date Title
CN113499393B (en) Composition with gastric mucosa injury protection effect and preparation method thereof
KR20080105825A (en) Herb composition useful for arthritis treatment or prevention and preparation thereof
CN107029146A (en) A kind of clearing lung and eliminating phlegm air making-up and spleen enlivening supports Chinese medicine composition of lung and preparation method thereof
CN103652360B (en) Feed for curing pig paratyphus and preparation method thereof
KR102567235B1 (en) Composition for the prevention and treatment of Inflammatory Bowl Disease
KR101930277B1 (en) Composition for Preventing and Improving Hangover
CN110237174A (en) A kind of eliminating dampness Chinese medicine composition and preparation method thereof for treating cold cough
CN105535495B (en) A kind of Chinese medicine composition and preparation method of the element culturing fixed folder treatment cancer of the esophagus
WO2016117705A1 (en) Agent for inducing production of hepatocyte growth factor
CN101254263A (en) Compound Japanese polygala oral liquid and method of preparing the same
CN107158302B (en) A natural pharmaceutical composition for protecting gastric mucosa, and its preparation method
JP2004352626A (en) Anticholesterol agent containing plant-derived component
CN101152223B (en) Use of poplar leaf phenols extract in preparation of medicine for treating cardiovascular disease
CN107712890A (en) A kind of antitoxic heart-soothing and sedative cream taste and preparation method thereof
CN108721557B (en) Traditional Chinese medicine composition with auxiliary protection function on gastric mucosa injury and preparation method and application thereof
CN106619870B (en) Composition for treating digestive system tumor and preparation method thereof
CN111084878A (en) Biological medicine and medical total nutrient food for lung and respiratory system diseases and preparation method thereof
JP4636475B2 (en) Antidiabetic
CN110585256A (en) Gynura procumbens preparation
CN107596013A (en) A kind of extracting method of maca and its male health-care product of preparation
CN102247470B (en) A kind of Chinese medicine composition preventing and treating infant upper respiratory tract infection
CN117562155A (en) Health tea with liver protecting effect
JP3308946B2 (en) Alcohol absorption inhibitor
Goel et al. A Clinical Approach of the Aerial Parts of Tinospora Cordifolia as an Anti-Inflammatory and Other Medicinal Properties
KR20230073516A (en) Composition for preventing or treating rheumatoid arthritis comprising Pinellia ternata, Wolfiporia extensa, Magnolia Officinalis, Perilla frutescens var. acuta and Zingiber officinale as active ingredients

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
CB02 Change of applicant information
CB02 Change of applicant information

Address after: 050000 Haihe Road 168, hi tech Zone, Shijiazhuang, Hebei

Applicant after: HEBEI YUZHILIN BIOTECHNOLOGY Co.,Ltd.

Applicant after: HEBEI YUZHILIN PHARMACEUTICAL Co.,Ltd.

Address before: 050000 No. 168, Huanghe Road, high tech Zone, Yuhua District, Shijiazhuang City, Hebei Province

Applicant before: HEBEI YUZHILIN BIOTECHNOLOGY Co.,Ltd.

Applicant before: HEBEI YUZHILIN PHARMACEUTICAL Co.,Ltd.

GR01 Patent grant
GR01 Patent grant
TR01 Transfer of patent right
TR01 Transfer of patent right

Effective date of registration: 20221018

Address after: 054000 five kilometers away from the east exit of Xingtai City, Hebei Province (Nanhe County Industrial Park)

Patentee after: HEBEI YUZHILIN PHARMACEUTICAL Co.,Ltd.

Address before: 050000 Haihe Road 168, hi tech Zone, Shijiazhuang, Hebei

Patentee before: HEBEI YUZHILIN BIOTECHNOLOGY Co.,Ltd.

Patentee before: HEBEI YUZHILIN PHARMACEUTICAL Co.,Ltd.